BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30747704)

  • 1. Increase in post-reperfusion sensitivity to tissue plasminogen activator-mediated fibrinolysis during liver transplantation is associated with abnormal metabolic changes and increased blood product utilisation.
    Moore HB; D'Alessandro A; Moore EE; Wither M; Lawson PJ; Huebner BR; Hansen K; Choudhury R; Nydam TL
    Blood Transfus; 2019 Jul; 17(4):312-320. PubMed ID: 30747704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation.
    Porte RJ; Bontempo FA; Knot EA; Lewis JH; Kang YG; Starzl TE
    Transplantation; 1989 Jun; 47(6):978-84. PubMed ID: 2499962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator.
    Dzik WH; Arkin CF; Jenkins RL; Stump DC
    Blood; 1988 Apr; 71(4):1090-5. PubMed ID: 3128347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis in patients with chemotherapy-induced thrombocytopenia and the effect of platelet transfusion.
    Heubel-Moenen FCJI; Henskens YMC; Verhezen PWM; Wetzels RJH; Schouten HC; Beckers EAM
    J Thromb Haemost; 2019 Jul; 17(7):1073-1084. PubMed ID: 31033178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.
    Pedersen OD; Gram J; Bagger H; Keller N; Jespersen J
    Coron Artery Dis; 1994 Jul; 5(7):617-23. PubMed ID: 7952424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo.
    Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Innerhofer P
    Br J Anaesth; 2008 Mar; 100(3):307-14. PubMed ID: 18158312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin.
    Segal HC; Hunt BJ; Cottam S; Downing A; Beard C; Francis JL; Potter D; Tan KC
    Transplantation; 1994 Dec; 58(12):1356-60. PubMed ID: 7528949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased fibrinolysis in orthotopic but not in heterotopic liver transplantation: the role of the anhepatic phase.
    Bakker CM; Metselaar HJ; Groenland TN; Terpstra OT; Stibbe J
    Transpl Int; 1992; 5 Suppl 1():S173-4. PubMed ID: 14621767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased tissue-type plasminogen activator activity in orthotopic but not heterotopic liver transplantation: the role of the anhepatic period.
    Bakker CM; Metselaar HJ; Groenland TN; Gomes MJ; Knot EA; Hesselink EJ; Schalm SW; Stibbe J; Terpstra OT
    Hepatology; 1992 Aug; 16(2):404-8. PubMed ID: 1639350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A kinetic model of the circulatory regulation of tissue plasminogen activator during orthotopic liver transplantation.
    Crookston KP; Marsh CL; Chandler WL
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):79-88. PubMed ID: 10691102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in urokinase-type plasminogen activator in orthotopic liver transplantation.
    Himmelreich G; Dooijewaard G; Breinl P; Bechstein WO; Blumhardt G; Kluft C; Riess H
    Semin Thromb Hemost; 1993; 19(3):311-4. PubMed ID: 7689759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
    Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
    Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators of fibrinolysis in orthotopic liver transplantation.
    Cheema SP; Webster NR; Dunn F; Bellamy MC
    Clin Transplant; 1996 Feb; 10(1 Pt 1):24-7. PubMed ID: 8652893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of long-term graft preservation on intraoperative hemostatic changes in liver transplantation. A comparison between orthotopic and heterotopic transplantation in the pig.
    Bakker CM; Blankensteijn JD; Schlejen P; Porte RJ; Gomes MJ; Lampe HI; Stibbe J; Terpstra OT
    HPB Surg; 1994; 7(4):265-80. PubMed ID: 8204546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.